CONCLUSIONS : Both nonobese clozapine- and olanzapine-treated groups displayed significant insulin resistance and impairment of glucose effectiveness compared with risperidone-treated subjects .
O O O O B-ChemicalEntity O B-ChemicalEntity O O O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O O O B-ChemicalEntity O O O B-ChemicalEntity O O